v3.26.3
Condensed Consolidated Statements of Equity (Deficit) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Mezzanine Equity at beginning of period (in shares) at Dec. 31, 2024 28,000.00001              
Mezzanine Equity at beginning of period at Dec. 31, 2024 $ 23,861              
Mezzanine Equity                
Conversion of convertible preferred stock (in shares) (28,000.00001)              
Conversion of convertible preferred stock $ (26,577)              
Preferred stock accretion $ 2,716              
Mezzanine Equity at end of period (in shares) at Sep. 30, 2025 0              
Mezzanine Equity at end of period at Sep. 30, 2025 $ 0              
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2024     89,861,035          
Stockholders' equity at beginning of period at Dec. 31, 2024   $ (7,731) $ 9 $ (5,445) $ 718,797 $ (27,455) $ (693,637)  
Stockholders’ Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     1,462,602          
Shares issued in connection with equity incentive plans   1 $ 1          
Stock-based compensation expense and vesting of restricted stock units   3,502     3,502      
Conversion of convertible preferred stock (in shares)     16,224,418          
Conversion of convertible preferred stock   26,577 $ 1   26,576      
Preferred stock accretion (2,716) (2,716)     (2,716)      
Other   (376)         (376)  
Sale of common stock (in shares)     191,260          
Sale of common stock, net   254     254      
Other comprehensive income (loss)   522       522    
Net income (loss) $ (16,260) (16,260)         (16,260)  
Common stock, shares outstanding at end of period (in shares) at Sep. 30, 2025     107,739,315          
Stockholders' equity at end of period at Sep. 30, 2025   3,773 $ 11 (5,445) 746,413 (26,933) (710,273)  
Mezzanine Equity at beginning of period (in shares) at Jun. 30, 2025 21,000.00001              
Mezzanine Equity at beginning of period at Jun. 30, 2025 $ 19,130              
Mezzanine Equity                
Conversion of convertible preferred stock (in shares) (21,000.00001)              
Conversion of convertible preferred stock $ (19,577)              
Preferred stock accretion $ 447              
Mezzanine Equity at end of period (in shares) at Sep. 30, 2025 0              
Mezzanine Equity at end of period at Sep. 30, 2025 $ 0              
Common stock, shares outstanding at beginning of period (in shares) at Jun. 30, 2025     94,665,825          
Stockholders' equity at beginning of period at Jun. 30, 2025   (17,490) $ 10 (5,445) 725,881 (27,203) (710,733)  
Stockholders’ Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     442,500          
Stock-based compensation expense and vesting of restricted stock units   1,149     1,149      
Conversion of convertible preferred stock (in shares)     12,439,730          
Conversion of convertible preferred stock   19,577 $ 1   19,576      
Preferred stock accretion   (447)     (447)      
Sale of common stock (in shares)     191,260          
Sale of common stock, net   254     254      
Other comprehensive income (loss)   270       270    
Net income (loss) $ 460 460         460  
Common stock, shares outstanding at end of period (in shares) at Sep. 30, 2025     107,739,315          
Stockholders' equity at end of period at Sep. 30, 2025   3,773 $ 11 (5,445) 746,413 (26,933) (710,273)  
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2025 112,819,881   112,819,881          
Stockholders' equity at beginning of period at Dec. 31, 2025 $ 18,375 18,375 $ 11 (5,445) 757,441 (26,716) (706,916) $ 0
Stockholders’ Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     6,154,337          
Shares issued in connection with equity incentive plans 0   $ 0          
Stock-based compensation expense and vesting of restricted stock units 5,878 5,878     5,878      
Shares withheld for taxes in connection with vested restricted stock units (in shares)     (952,133)          
Shares withheld for taxes in connection with vested restricted stock units (1,828) (1,828)   (1,828)        
Repurchase of shares pursuant to a stock repurchase agreement (in shares)     (4,761,905)          
Repurchase of shares pursuant to a stock repurchase agreement (17,020) (17,020) $ (1) (5,000) (12,019)      
Preferred stock accretion 0              
Issuance and sale of noncontrolling equity interest (Note 9) 15,003 14,202     14,202     801
Noncontrolling interest capital contribution 3,425 3,425     3,425      
Release of indemnity holdback shares (in shares)     249,116          
Release of indemnity holdback shares 297 297     297      
Shares issued pursuant to a backstop agreement, net of fees (in shares)     101,790          
Sale of common stock (in shares)     3,666,783          
Sale of common stock, net 5,495 5,495 $ 1   5,494      
Other comprehensive income (loss) 542 542       542    
Net income (loss) $ (1,901) (1,901)         (1,901)  
Common stock, shares outstanding at end of period (in shares) at Sep. 30, 2026 117,277,869   117,277,869          
Stockholders' equity at end of period at Sep. 30, 2026 $ 28,266 27,465 $ 11 (12,273) 774,718 (26,174) (708,817) 801
Common stock, shares outstanding at beginning of period (in shares) at Jun. 30, 2026     118,353,343          
Stockholders' equity at beginning of period at Jun. 30, 2026 22,856 22,055 $ 11 (9,273) 767,983 (25,985) (710,681) 801
Stockholders’ Equity (Deficit)                
Shares issued in connection with equity incentive plans (in shares)     1,148,974          
Stock-based compensation expense and vesting of restricted stock units 2,210 2,210     2,210      
Repurchase of shares pursuant to a stock repurchase agreement (in shares)     (2,857,143)          
Repurchase of shares pursuant to a stock repurchase agreement (1) (1)   (3,000) 2,999      
Noncontrolling interest capital contribution 1,023 1,023     1,023      
Release of indemnity holdback shares (in shares)     249,116          
Release of indemnity holdback shares 297 297     297      
Shares issued pursuant to a backstop agreement, net of fees (in shares)     101,790          
Sale of common stock (in shares)     281,789          
Sale of common stock, net 206 206     206      
Other comprehensive income (loss) (189) (189)       (189)    
Net income (loss) $ 1,864 1,864         1,864  
Common stock, shares outstanding at end of period (in shares) at Sep. 30, 2026 117,277,869   117,277,869          
Stockholders' equity at end of period at Sep. 30, 2026 $ 28,266 $ 27,465 $ 11 $ (12,273) $ 774,718 $ (26,174) $ (708,817) $ 801